International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
Autorzy :
Morgan E; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France .; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK. Soerjomataram I; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Gavin AT; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK. Rutherford MJ; Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, UK. Gatenby P; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, UK. Bardot A; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Ferlay J; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Bucher O; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada. De P; Surveillance and Cancer Registry, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada. Engholm G; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark. Jackson C; Cancer Society of New Zealand, Wellington, New Zealand.; Department of Medicine, Otago Medical School, Dunedin, New Zealand. Kozie S; Saskatchewan Cancer Agency, Regina, Saskatchewan, Canada. Little A; Cancer Information and Analysis, Cancer Institute NSW, Alexandria, New South Wales, Australia. Møller B; Department of Registration, Cancer Registry of Norway, Oslo, Norway. Shack L; Cancer Control Alberta, Alberta Health Services, Edmonton, Alberta, Canada. Tervonen H; Cancer Information and Analysis, Cancer Institute NSW, Alexandria, New South Wales, Australia. Thursfield V; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, Victoria, Australia. Vernon S; National Cancer Registration and Analysis Service, Public Health England, Cambridge, UK. Walsh PM; National Cancer Registry Ireland, Cork, Ireland. Woods RR; BC Cancer Agency, Vancouver, British Columbia, Canada. Finley C; Department of Surgery, McMaster University, Hamilton, Ontario, Canada. Merrett N; School of Medicine, Western Sydney University, Sydney, New South Wales, Australia. O'Connell DL; Cancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia. Reynolds JV; National Centre for Oesophageal Cancer, St James's Hospital and Trinity College Dublin, Dublin, Ireland. Bray F; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. ArnoldM; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
Pokaż więcej
Źródło :
Gut [Gut] 2021 Feb; Vol. 70 (2), pp. 234-242. Date of Electronic Publication: 2020 Jun 17.
Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses.
Autorzy :
Sun L; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Pennells L; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Kaptoge S; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Nelson CP; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom. Ritchie SC; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. Abraham G; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. ArnoldM; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Bell S; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Bolton T; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Burgess S; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Dudbridge F; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.; Department of Health Sciences, University of Leicester, Leicester, United Kingdom. Guo Q; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Sofianopoulou E; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Stevens D; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Thompson JR; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom. Butterworth AS; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Wood A; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Danesh J; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom. Samani NJ; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.; Department of Health Sciences, University of Leicester, Leicester, United Kingdom. Inouye M; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.; The Alan Turing Institute, London, United Kingdom. Di Angelantonio E; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Pokaż więcej
Źródło :
PLoS medicine [PLoS Med] 2021 Jan 14; Vol. 18 (1), pp. e1003498. Date of Electronic Publication: 2021 Jan 14 (Print Publication: 2021).
Neovagina stricture complicated by high-grade dysplasia in a patient with history of cloaca and ulcerative colitis: a case report and review of the literature.
Autorzy :
Alaniz VI; Children's Hospital Colorado, 13123 East 16th Ave B467, Aurora, CO, 80045, USA. . Wilcox DT; Children's Hospital Colorado, 13123 East 16th Ave B467, Aurora, CO, 80045, USA. ArnoldM; Children's Hospital Colorado, 13123 East 16th Ave B467, Aurora, CO, 80045, USA. Bodmer JL; Children's Hospital Colorado, 13123 East 16th Ave B467, Aurora, CO, 80045, USA. de la Torre L; Children's Hospital Colorado, 13123 East 16th Ave B467, Aurora, CO, 80045, USA. Peña A; Children's Hospital Colorado, 13123 East 16th Ave B467, Aurora, CO, 80045, USA. Bischoff A; Children's Hospital Colorado, 13123 East 16th Ave B467, Aurora, CO, 80045, USA.
The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study.
Autorzy :
Andersson TM; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: therese.m. Myklebust TÅ; Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway. Rutherford MJ; Department of Health Sciences, University of Leicester, Leicester, United Kingdom; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Møller B; Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway. Soerjomataram I; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France. ArnoldM; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Bray F; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Parkin DM; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. Sasieni P; King's College London, Clinical Trials Unit, London, United Kingdom. Bucher O; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada. De P; Analytics and Informatics, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada. Engholm G; Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark. Gavin A; Northern Ireland Cancer Registry, Queen's University Belfast, Northern Ireland, United Kingdom. Little A; Cancer Institute NSW, Alexandria, NSW, Australia. Porter G; Canadian Partnership Against Cancer, Toronto, Ontario, Canada. Ramanakumar AV; Research-Institute, McGill University Health Center, Montreal, Quebec, Canada. Saint-Jacques N; Nova Scotia Health Cancer Care Program, Registry & Analytics, Halifax, Nova Scotia, Canada. Walsh PM; National Cancer Registry Ireland, Cork, Ireland. Woods RR; Cancer Control Research, BC Cancer, Vancouver, British Columbia, Canada. Lambert PC; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
Pokaż więcej
Źródło :
Cancer epidemiology [Cancer Epidemiol] 2021 Jan 10; Vol. 71 (Pt A), pp. 101881. Date of Electronic Publication: 2021 Jan 10.
Hypothalamic detection of macronutrients via multiple gut-brain pathways.
Autorzy :
Goldstein N; Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA. McKnight AD; Monell Chemical Senses Center, Philadelphia, PA 19104, USA; Department of Neuroscience, University of Pennsylvania, Philadelphia, PA 19104, USA. Carty JRE; Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA. ArnoldM; Department of Health Sciences and Technology, ETH Zurich, Switzerland. Betley JN; Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: . Alhadeff AL; Monell Chemical Senses Center, Philadelphia, PA 19104, USA; Department of Neuroscience, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell metabolism [Cell Metab] 2021 Jan 07. Date of Electronic Publication: 2021 Jan 07.
A case report: Actinobaculum suis infection associated with formation of pyogranuloma, epididymitis and azoospermia in a boar.
Autorzy :
ArnoldM; Department of Clinical Veterinary Medicine, Clinic for Swine, Vetsuisse Faculty, University of Bern, CH, Bern, Switzerland. Mirjam.arnold@vetsuisse.unibe.ch. Richard O; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, Institute of Animal Pathology, University of Bern, CH, Bern, Switzerland. Gurtner C; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, Institute of Animal Pathology, University of Bern, CH, Bern, Switzerland. Nathues H; Department of Clinical Veterinary Medicine, Clinic for Swine, Vetsuisse Faculty, University of Bern, CH, Bern, Switzerland. Grahofer A; Department of Clinical Veterinary Medicine, Clinic for Swine, Vetsuisse Faculty, University of Bern, CH, Bern, Switzerland.
Pokaż więcej
Źródło :
BMC veterinary research [BMC Vet Res] 2021 Jan 06; Vol. 17 (1), pp. 6. Date of Electronic Publication: 2021 Jan 06.
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank.
Autorzy :
Allen NE; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, OXFORD, Oxon, OX3 7LF, UK.; UK Biobank, Stockport, Cheshire, SK3 0SA, UK. ArnoldM; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, OXFORD, Oxon, OX3 7LF, UK. Parish S; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, OXFORD, UK. Hill M; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, OXFORD, UK. Sheard S; UK Biobank, Stockport, Cheshire, SK3 0SA, UK. Callen H; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, OXFORD, Oxon, OX3 7LF, UK.; UK Biobank, Stockport, Cheshire, SK3 0SA, UK. Fry D; UK Biobank, Stockport, Cheshire, SK3 0SA, UK. Moffat S; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, OXFORD, UK. Gordon M; UK Biobank, Stockport, Cheshire, SK3 0SA, UK. Welsh S; UK Biobank, Stockport, Cheshire, SK3 0SA, UK. Elliott P; MRC Centre for Environment and Health, Imperial College London, London, UK. Collins R; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, OXFORD, Oxon, OX3 7LF, UK.; UK Biobank, Stockport, Cheshire, SK3 0SA, UK.
Pokaż więcej
Źródło :
Wellcome open research [Wellcome Open Res] 2021 Jan 04; Vol. 5, pp. 222. Date of Electronic Publication: 2021 Jan 04 (Print Publication: 2020).
Multi-omics integration in biomedical research - A metabolomics-centric review.
Autorzy :
Wörheide MA; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. Krumsiek J; Institute for Computational Biomedicine, Englander Institute for Precision Medicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA. Kastenmüller G; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany. ArnoldM; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA. Electronic address: matthias.arnold@helmholtz-muenchen.de.
Pokaż więcej
Źródło :
Analytica chimica acta [Anal Chim Acta] 2021 Jan 02; Vol. 1141, pp. 144-162. Date of Electronic Publication: 2020 Oct 22.
Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease.
Autorzy :
Salazar AM; Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA. Leisgang AM; Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA. Ortiz AA; Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA. Murtishaw AS; Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA. Kinney JW; Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA. Electronic address: .
Pokaż więcej
Źródło :
Neurobiology of aging [Neurobiol Aging] 2021 Jan; Vol. 97, pp. 129-143. Date of Electronic Publication: 2020 Oct 23.
Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.
Autorzy :
Meinel TR; Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Branca M; Clinicial Trials Unit Bern, University of Bern, Bern, Switzerland. De Marchis GM; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland. Nedeltchev K; Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland. Kahles T; Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland. Bonati L; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland. ArnoldM; Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Heldner MR; Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Jung S; Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Carrera E; Department of Neurology, Hôpitaux Universitaires de Genève, Geneva, Switzerland. Dirren E; Department of Neurology, Hôpitaux Universitaires de Genève, Geneva, Switzerland. Michel P; Stroke Center, Neurology Service, Lausanne University Hospital, Lausanne, Switzerland. Strambo D; Stroke Center, Neurology Service, Lausanne University Hospital, Lausanne, Switzerland. Cereda CW; Stroke Center, Neurocenter of Southern Switzerland, Lugano, Switzerland. Bianco G; Stroke Center, Neurocenter of Southern Switzerland, Lugano, Switzerland. Kägi G; Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland. Vehoff J; Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland. Katan M; Department of Neurology, University Hospital Zurich, Basel, Switzerland. Bolognese M; Neurocenter, Cantonal Hospital of Lucerne, Lucerne, Switzerland. Backhaus R; Hirslanden Hospital Zurich, Glattpark, Switzerland. Salmen S; Spitalzentrum Biel, Biel, Switzerland. Albert S; Cantonal Hospital Graubuenden, Chur, Switzerland. Medlin F; Stroke Unit, Cantonal Hospital Fribourg, Fribourg, Switzerland. Berger C; Spital Sarganserland Grabs, Grabs, Switzerland. Schelosky L; Neurology, Cantonal Hospital Münsterlingen, Münsterlingen, Switzerland. Renaud S; Neurology, Cantonal Hospital Neuchatel, Neuchâtel, Switzerland. Niederhauser J; Stroke Unit, Groupement hospitalier de l'ouest lémanique, Nyon, Switzerland. Bonvin C; Hôpital du Valais, Sion, Switzerland. Schaerer M; Bürgerspital Solothurn, Solothurn, Switzerland. Mono ML; Stadtspital Waid und Triemli, Zurich, Switzerland. Rodic B; Cantonal Hospital Winterthur, Winterthur, Switzerland. Tarnutzer AA; Cantonal hospital of Baden, Baden, Switzerland. Mordasini P; Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Gralla J; Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Kaesmacher J; Department of Neurology, Institute of Diagnostic and Interventional Neuroradiology, Institute of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Engelter S; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland.; Neurology and Neurorehabilitation, University Department of Geriatic Medicine Felix Platter, University of Basel, Basel, Switzerland. Fischer U; Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Seiffge DJ; Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
Autorzy :
Araghi M; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. ArnoldM; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Rutherford MJ; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.; Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, UK. Guren MG; Department of Oncology and K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway. Cabasag CJ; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Bardot A; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Ferlay J; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Tervonen H; Cancer Institute NSW, Alexandria, New South Wales, Australia. Shack L; Cancer Control Alberta, Alberta Health Services, Calgary, Alberta, Canada. Woods RR; BC Cancer Agency, Vancouver, British Columbia, Canada. Saint-Jacques N; Registry & Analytics, Nova Scotia Health Authority Cancer Care Program, Halifax, Nova Scotia, Canada. De P; Surveillance and Cancer Registry, Cancer Care Ontario, Toronto, Ontario, Canada. McClure C; PEI Cancer Registry, Charlottetown, Prince Edward Island, Canada. Engholm G; Cancer Prevention & Documentation, Danish Cancer Society, Copenhagen, Denmark. Gavin AT; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK. Morgan E; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK. Walsh PM; National Cancer Registry Ireland, Cork, Ireland. Jackson C; Cancer Society of New Zealand Inc, Wellington, New Zealand. Porter G; Canadian Partnership Against Cancer, Toronto, Ontario, Canada. Møller B; Institute of Population-Based Cancer Research, Cancer Registry of Norway, Oslo, Norway. Bucher O; Population Oncology, CancerCare Manitoba, Winnipeg, Manitoba, Canada. Eden M; National Cancer Registry and Analysis Service, London, UK. O'Connell DL; Cancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia. Bray F; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. Soerjomataram I; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France .
Pokaż więcej
Źródło :
Gut [Gut] 2021 Jan; Vol. 70 (1), pp. 114-126. Date of Electronic Publication: 2020 Jun 01.
Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice.
Autorzy :
Lauten A; Department for Cardiology, Helios Clinic, Erfurt, Germany. Rudolph TK; Department of Cardiology, Hear and Diabetes Center Bad Oeynhausen, Ruhr-University of Bochum, Bad Oeynhausen, Germany. Messika-Zeitoun D; University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Thambyrajah J; James Cook University Hospital, Middlesbrough, UK. Serra A; Interventional Cardiology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain. Schulz E; Cardiology Department, AKH Celle, Celle, Niedersachsen, Germany. Frey N; Department of Cardiology and Angiology, University of Kiel, Kiel, Schleswig-Holstein, Germany. Maly J; Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.; Department of Cardiovascular Surgery, Second Faculty of Medicine, Charles University, Prague, Czech Republic. Aiello M; Department of Cardiothoracic Surgery, Foundation IRCCS Policlinico S.Matteo, Pavia, Italy. Lloyd G; St Bartholomew's Hospital, London, UK. Bortone AS; University of Bari, Bari, Puglia, Italy. Clerici A; University of Turin, Turin, Piemonte, Italy. Delle-Karth G; 4th Medical Department, Hietzing Hospital, Vienna, Austria. Rieber J; Herzkatheterlabor Nymphenburg and Department of Cardiology, University of Munich, Munich, Bayern, Germany. Indolfi C; Division of Cardiology and URT CNR of IFC, University Magna Graecia, Catanzaro, Calabria, Italy. Mancone M; Sapienza University of Rome, Rome, Italy. Belle L; Centre Hospital d'Annecy, Annecy, France. ArnoldM; Department of Cardiology, University Hospital Erlangen, Erlangen, Bayern, Germany. Bouma BJ; University of Amsterdam, Amsterdam, Netherlands. Lutz M; Department of Cardiology and Angiology, University of Kiel, Kiel, Schleswig-Holstein, Germany. Deutsch C; Institut für Pharmakologie und Präventive Medizin GmbH, Cloppenburg, Germany. Kurucova J; Edwards Lifesciences, Prague, Czech Republic. Thoenes M; Edwards Lifesciences, Nyon, Switzerland. Bramlage P; Institut für Pharmakologie und Präventive Medizin GmbH, Cloppenburg, Germany . Steeds RP; Queen Elizabeth Hospital & Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
IMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe.
Autorzy :
Steeds RP; Queen Elizabeth Hospital & Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. Messika-Zeitoun D; University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Thambyrajah J; James Cook University Hospital, Middlesbrough, UK. Serra A; Interventional Cardiology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Schulz E; Cardiology Department, AKH Celle, Celle, Germany. Maly J; Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.; Department of Cardiovascular Surgery, Second Faculty of Medicine, Charles University, Prague, Czech Republic. Aiello M; Department of Cardiothoracic Surgery, Foundation IRCCS Policlinico S.Matteo, Pavia, Italy. Rudolph TK; Department of Cardiology, Heart and Diabetes Center Bad Oeynhausen, Ruhr-University of Bochum, Bad Oeynhausen, Germany. Lloyd G; St Bartholomew's Hospital, London, UK. Bortone AS; University of Bari, Bari, Italy. Clerici A; University of Turin, Turin, Italy. Delle-Karth G; 4th Medical Department, Hietzing Hospital, Vienna, Austria. Rieber J; Herzkatheterlabor Nymphenburg and Department of Cardiology, University of Munich, Munich, Germany. Indolfi C; Division of Cardiology and URT CNR of IFC, University Magna Graecia, Catanzaro, Italy. Mancone M; Sapienza University of Rome, Rome, Italy. Belle L; Centre Hospital d'Annecy, Annecy, France. Lauten A; Department for Cardiology, Helios Erfurt Clinic, Erfurt, Germany. ArnoldM; Department of Cardiology, University of Erlangen, Erlangen, Germany. Bouma BJ; University of Amsterdam, Amsterdam, Netherlands. Lutz M; Department of Cardiology and Angiology, University of Kiel, Kiel, Germany. Deutsch C; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany. Kurucova J; Edwards Lifesciences, Prague, Czech Republic. Thoenes M; Edwards Lifesciences, Nyon, Switzerland. Bramlage P; Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany . Frey N; Department of Cardiology and Angiology, University of Kiel, Kiel, Germany.
Utilization of government healthcare services by adult leprosy patients in the Western Province, Sri Lanka.
Autorzy :
Liyanage NR; National Programme for Tuberculosis Control and Chest Disease, Ministry of Health, Colombo, Sri Lanka. ArnoldM; Quarantine Unit, Ministry of Health, Colombo, Sri Lanka. Wijesinghe S; Health Promotion Bureau, Ministry of Health, Colombo, Sri Lanka.
Pokaż więcej
Źródło :
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Dec 31; Vol. 14 (12), pp. e0008973. Date of Electronic Publication: 2020 Dec 31 (Print Publication: 2020).
Neurons populating the rectal extrinsic nerves in humans express neuronal and Schwann cell markers.
Autorzy :
Woods C; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado, Aurora, CO, USA. Kapur RP; Department of Pathology, Seattle Children's Hospital and University of Washington, Seattle, WA, USA. Bischoff A; Department of Pediatric Surgery, International Center for Colorectal and Urogenital Care, Children's Hospital Colorado, Aurora, CO, USA. Lovell M; Department of Pathology, Children's Hospital Colorado, Aurora, CO, USA. ArnoldM; Department of Pathology, Children's Hospital Colorado, Aurora, CO, USA. Peña A; Department of Pediatric Surgery, International Center for Colorectal and Urogenital Care, Children's Hospital Colorado, Aurora, CO, USA. Flockton A; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado, Aurora, CO, USA. Sharkey KA; Department of Physiology & Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Belkind-Gerson J; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado, Aurora, CO, USA.; Neurogastroenterology and Motility Program, Digestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA.
Why does Pharmac neglect inflammatory bowel disease?
Autorzy :
McCombie A; Research Officer and Data Analyst, Department of General Surgery, Canterbury District Health Board; Honorary Senior Research Fellow, University of Otago, Christchurch; Executive Committee Elected Member, New Zealand Society of Gastroenterology. ArnoldM; Consultant Gastroenterologist, Department of Gastroenterology, Canterbury District Health Board; President of the New Zealand Society of Gastroenterology. O'Connor M; Clinical Nurse Specialist, Taranaki District Health Board; Co-chair of the NZ IBD Nursing Group, GENCA Board Director. Stein R; Chairman, Crohn's and Colitis New Zealand Charitable Trust; Clinical Senior Lecturer, University of Otago, Wellington. Fulforth J; Consultant Gastroenterologist, Department of Gastroenterology, Waikato District Health Board. Brown B; Operations Manager, Crohn's and Colitis New Zealand Charitable Trust. Gearry R; Consultant Gastroenterologist, Department of Gastroenterology, Canterbury District Health Board; Head of Department, Department of Medicine, University of Otago, Christchurch.
Pokaż więcej
Źródło :
The New Zealand medical journal [N Z Med J] 2020 Dec 18; Vol. 133 (1527), pp. 111-115. Date of Electronic Publication: 2020 Dec 18.
European experience with a first totally leadless cardiac resynchronization therapy pacemaker system.
Autorzy :
Carabelli A; Arrhythmias Unit, Department of Cardiology, Grenoble University Hospital, CS 10217, 38043 Grenoble Cedex 09, France. Jabeur M; Arrhythmias Unit, Department of Cardiology, Grenoble University Hospital, CS 10217, 38043 Grenoble Cedex 09, France. Jacon P; Arrhythmias Unit, Department of Cardiology, Grenoble University Hospital, CS 10217, 38043 Grenoble Cedex 09, France. Rinaldi CA; Cardiology Department, Guy's & St Thomas' Hospitals, Westminster Bridge Road, London SE1 7EH, UK. Leclercq C; Cardiology and vascular diseases Division, Rennes University Hospital, 35033 Rennes, France. Rovaris G; Cardiology and Electrophysiology Unit, San Gerardo Hospital, 20900 Monza, Italy. ArnoldM; Department of Cardiology, University of Erlangen-Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany. Venier S; Arrhythmias Unit, Department of Cardiology, Grenoble University Hospital, CS 10217, 38043 Grenoble Cedex 09, France. Neuzil P; Cardiology Department, Na Homolce Hospital, Roentgenova 2, Prague 515030, Czech Republic. Defaye P; Arrhythmias Unit, Department of Cardiology, Grenoble University Hospital, CS 10217, 38043 Grenoble Cedex 09, France.
Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study.
Autorzy :
Andersson TM; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. therese.m. Rutherford MJ; Department of Health Sciences, University of Leicester, Leicester, UK.; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Myklebust TÅ; Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway.; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway. Møller B; Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway. Soerjomataram I; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France. ArnoldM; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Bray F; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Parkin DM; Cancer Surveillance Section, International Agency for Research on Cancer (IARC/WHO), Lyon, France.; Nuffield Department of Population Health, University of Oxford, Oxford, UK. Sasieni P; King's College London, Clinical Trials Unit, London, UK. Bucher O; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada. De P; Analytics and Informatics, Ontario Health (Cancer Care Ontario), Toronto, ON, Canada. Engholm G; Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark. Gavin A; Northern Ireland Cancer Registry, Queen's University Belfast, Northern Ireland, UK. Little A; Cancer Institute NSW, Alexandria, NSW, Australia. Porter G; Canadian Partnership Against Cancer, Toronto, ON, Canada. Ramanakumar AV; Research-Institute, McGill University Health Center, Montreal, QC, Canada. Saint-Jacques N; Nova Scotia Health Authority Cancer Care Program, Registry & Analytics, Halifax, NS, Canada. Walsh PM; National Cancer Registry, Ireland, Cork, Ireland. Woods RR; Cancer Control Research, BC Cancer, Vancouver, BC, Canada. Lambert PC; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Health Sciences, University of Leicester, Leicester, UK.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
W koszyku znajdują się zamówienia
W koszyku znajdują się zamówienia do wysłania. Czy chcesz wysłać je do realizacji?
